Today’s AI Top Pick: MORN
7/22/2026 · Low Float Bullish Consensus Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live MORN price forecast →
Morningstar is the cleanest quality name in this low-float basket, and the tape is finally lining up with the fundamentals. On the fundamentals side it is the best-scored candidate here (fundamental_score 8): PE 16.89, fwdPE 12.32, PEG 0.71, ROE 30.66%, profit margin 16.06%, sales YoY +8.39%, institutional ownership 62.94%, recom 1.67, and targetUpsidePct +36.4%. That is a rare combination of value + quality in a name that has already been punished (perfYtd -23.75%, perfYear -41.41%), so we are not chasing an extended winner — we are buying a beaten-down compounder with float and consensus support. The multi-timeframe forecast tape confirms. 4h fc +7.20/+7.29/+14.33, 1d fc +19.02/+21.59/+26.62, and 1wk fc +18.36/+40.04/+50.90 all point the same direction with rising magnitude into the mid/long horizon. Kronos bullish_prob = 1.0 and near_term_bullish = 1.0. The only blemish is the 1h fc_short at -2.45%, which is noise given the higher-timeframe alignment. Weekly pos_in_21bar_range is 34.87% with dd_from_21bar_high -12.34% — mid-range on the swing chart, not chasing highs. Compare to the other quality names: HURN has a great daily setup but its 1wk fc is negative across all horizons (-12.16/-8.87/-7.21), which is a red flag. USLM and IDR both sit at 82–100% of the 1h/4h range and have deeply negative weekly forecasts (USLM 1wk -11/-24/-38; IDR 1wk -35/-63/-81) — extended, don't chase. CSV is a legitimate #2 with all four TFs positive and pos_in_range near 0, but its forecast magnitude (1wk only +2.87/+9.22/+5.54) is a fraction of MORN's, and StockStory just published a 'Reasons to Sell CSV' piece. Recent headlines are neutral-to-supportive for MORN (PitchBook 'Best Alternative Data Provider' award, small-cap value narrative). No dilution, no legal overhang, no guidance cut. TODAY is the right entry because we're mid-range on the weekly with a Kronos-forecast +40–51% into the long horizon and PEG 0.71 — waiting for a deeper pullback risks missing the mean-reversion off the -41% one-year drawdown.
- Debt/Equity 1.87 is elevated for a data/services firm — rate or credit shock could re-rate multiple lower
- 1h fc_short -2.45% and dd_from_21bar_high -3.97% suggest possible short-term chop before the higher-TF thesis plays out
- 6.3B market cap makes this the largest name in the low-float lens — expect less asymmetric upside than the micro-caps if the thesis works
- perfYear -41.41% means we're catching a knife; a break of $154 invalidates the mean-reversion setup
- 1wk recent_21bar_pct -12.34% shows the weekly trend is still down — forecast is calling a turn that hasn't confirmed on price yet
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | MORN | BUY NOW | 8.6 | Best fundamentals in the pool (PEG 0.71, ROE 30.7%) with 4h/1d/1wk forecasts all positive and rising to +50.9% long-horizon. |
| 2 | CSV | BUY NOW | 8.0 | All four TFs bullish, pos_in_range 0% on higher TFs = deeply oversold with no chase risk, recom 1.2. |
| 3 | HURN | BUY PULLBACK | 7.2 | Strong daily setup and fundamentals but 1wk forecast is negative across all horizons — wait for the weekly to turn. |
| 4 | TASK | BUY PULLBACK | 6.6 | Cheap (fwdPE 3.8) with strong 1d fc +39.7/+42.2/+35, but pos_in_range 87.9% on daily = extended, and recom 2.86 is weak. |
| 5 | USLM | WAIT | 6.2 | Great margins (41.6% oper) but pos_in_range 82–90% on lower TFs and 1wk fc deeply negative (-38.24% long). |
| 6 | IDR | WAIT | 5.8 | Strong rare-earth story and 43% profit margin, but 1h at 100% of range and 1wk fc -34.7/-62.9/-80.6 — extended and mean-reverting down. |
| 7 | AKTX | BUY PULLBACK | 5.6 | Maxim upgrade to Buy with $30 PT and 1d fc +46/+123/+80, but ROE -155% and near a 1h low — speculative bounce trade. |
| 8 | BCDA | BUY PULLBACK | 5.5 | Near_term_bullish 1.0 with 1d fc +43.7/+59/+49 and FDA support headline in June, but salesYoY -100% and micro-cap dilution risk. |
| 9 | BESS | WAIT | 5.4 | fwdPE 2.59 and 1d fc +45/+87/+88 but perfYtd -69% and heavy 4h/1d drawdown — needs base before entry. |
| 10 | NXTC | WAIT | 5.3 | Just merged into Avere with $320M PIPE and 90% CVR structure — thesis totally changed, unclear pro-forma setup. |
| 11 | DRMA | BUY PULLBACK | 5.0 | 1d fc +56/+110/+159 and no dilution news, but 1h fc negative and $5M market cap = extreme risk. |
| 12 | IDN | WAIT | 4.9 | Turned profitable on SaaS revenue with 90.7% gross margin, but pos_in_range 0% on 4h and 1wk fc turning negative long — trend still broken. |
| 13 | GLMD | BUY PULLBACK | 4.8 | Positive patent + cardiac formulation catalysts and 1d fc +70/+115/+122, but micro-cap and pos_in_range 6% shows no accumulation yet. |
| 14 | RGNT | WAIT | 4.7 | Recent Japan/EU regulatory wins and prior 850% surge, but bullish_prob null and 1d recent_21bar -58% — too erratic. |
| 15 | EVGN | BUY PULLBACK | 4.6 | All-TF alignment and 1wk fc +54/+170/+416 with AI drug discovery catalyst, but salesYoY -72.7% and operMargin -757%. |
| 16 | XTLB | WAIT | 4.4 | perfYtd +25.9% and 1d fc +34.7/+40.4/+31.9, but pos_in_range 100% on 1h — extended, and 1h fc negative. |
| 17 | QNTM | BUY PULLBACK | 4.3 | Near_term_bullish 1.0 and 1wk fc +312/+1048, but ROE -984% and no revenue — lottery ticket. |
| 18 | MBRX | AVOID | 4.0 | MIRACLE trial data 'fell short of significance' on 6/30 (-25% drop) — recent headline undercuts the forecast. |
| 19 | TGEN | WAIT | 4.0 | $3.3M orders and $8M backlog positive, but 1d recent_21bar -40% and Simply Wall St. cut fair value on data center order scrutiny. |
| 20 | YCBD | WAIT | 3.8 | New Mexcor distribution deal but 1d pos_in_range 1.17% and bullish_prob only 0.6. |
| 21 | LTRN | WAIT | 3.7 | New ZetaOmics AI platform positive, but pos_in_range 0% on 1h/4h/1d and epsNextY -33.77% — trend down. |
| 22 | SHOE | WAIT | 3.7 | PE 10.78 and recom 2.33 mixed, salesYoY -4.4% and shortFloat 21% — no near-term catalyst. |
| 23 | AKTX_dup | WAIT | 3.6 | placeholder — removed |
| 24 | WW | AVOID | 3.5 | bullish_prob null, recom 2.33, salesYoY -9.6%, only one TF available — broken setup. |
| 25 | HCWB | AVOID | 3.4 | 1-for-6 reverse split on 6/30 to regain compliance — classic dilution/distress signal despite big forecast numbers. |
| 26 | BTCT | AVOID | 3.2 | Just announced private placement on 7/9 (dilution) with no 1d timeframe data and pos_in_range 0% everywhere. |
| 27 | LUCY | AVOID | 3.1 | $3M warrant exercise on 7/8 = active dilution overhang; recom 3 (hold), pos_in_range ~0%. |
| 28 | IPWR | AVOID | 2.9 | Filed $75M mixed shelf on 7/10 — massive dilution risk against $69M mcap wipes out the NVIDIA LOI narrative. |
| 29 | VEEE | AVOID | 2.8 | recent_21bar +331% on 1d — pure chase; merger with USFM subsidiary already priced in, near_term_bullish only 0.2. |
| 30 | USBC | AVOID | 2.6 | 1d fc negative -41/-35/-16, bullish_prob 0.6, ROE -247%, targetUpside 11,011% is nonsense — data-quality flag. |
| 31 | DARE | AVOID | 2.5 | RSI 20.5 (extreme oversold but no catalyst), debtEq 9.84, profitMargin -1039% — no confirming near-term bounce signal. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord